Gastric pentadecapeptide preclinical 12x daily 250500 mcg Thymosin Beta-4 fragment Phase 1 safety data 2x weekly loading 22.5 mg Alpha-MSH anti-inflammatory tripeptide preclinical daily 200500 mcg Copper peptide preclinical daily 12 mg Growth Hormone Secretagogues Peptides that stimulate natural growth hormone release from the pituitary gland
How to prevent it: Start at 2 to 3 times per week for the first 2 weeks
Standard AOD-9604 Dosing : Dose: 0.20.3 mg per injection Frequency: Once or twice daily Timing: Morning: Ideally before fasted cardio or 12 hours before breakfast Evening: 13 hours after dinner, before bedtime Targeting Fat Loss Inject into areas with stubborn fat (e.g., abdomen, thighs) Best results occur when combined with exercise and a clean diet Cycle Duration : Loading Phase: 46 weeks of daily use Maintenance Phase: 23 injections per week to sustain results Breaks: Optional 12 week breaks every few months to avoid receptor desensitization Why Timing Matters : Administering AOD-9604 on an empty stomach enhances absorption Pairing with fasted cardio may amplify lipolytic effects Side Effects to Watch For : Mild nausea Headaches Localized irritation at injection site These are rare and typically resolve quickly

AOD-9604: Does not cause receptor burnout Does not require washout periods Does not lose effectiveness due to continuous use Consistency, not cycling, aligns with how it was designed to work
The lower abdomen is the most popular injection site due to its accessibility and subcutaneous fat layer
It is important to use Sermorelin under the guidance of a healthcare professional in clinical practice to ensure safety and effectiveness